Bacterial proteomics and its role in antibacterial drug discovery

被引:58
作者
Brötz-Oesterhelt, H
Bandow, JE
Labischinski, H
机构
[1] Bayer HealthCare, Anti Infect Res, Wuppertal, Germany
[2] Pfizer Inc, PGRD, Ann Arbor, MI USA
关键词
2D gel electrophoresis; proteomics; antibiotics; drug discovery; bacteria;
D O I
10.1002/mas.20030
中图分类号
O433 [光谱学];
学科分类号
0703 ; 070302 ;
摘要
Gene-expression profiling technologies in general, and proteomic technologies in particular have proven extremely useful to study the physiological response of bacterial cells to various environmental stress conditions. Complex protein toolkits coordinated by sophisticated regulatory networks have evolved to accommodate bacterial survival under ever-present stress conditions such as varying temperatures, nutrient availability, or antibiotics produced by other microorganisms that compete for habitat. In the last decades, application of man-made antibacterial agents resulted in additional bacterial exposure to antibiotic stress. Whereas the targeted use of antibiotics has remarkably reduced human suffering from infectious diseases, the ever-increasing emergence of bacteria that are resistant to antibiotics has led to an urgent need for novel antibiotic strategies. The intent of this review is to present an overview of the major achievements of proteomic approaches to study adaptation networks that are crucial for bacterial survival with a special emphasis on the stress induced by antibiotic treatment. A further focus will be the review of the, so far few, published efforts to exploit the knowledge derived from bacterial proteomic studies directly for the antibacterial drug-discovery process. (c) 2004 Wiley Periodicals, Inc., Mass Spec Rev 24:549-565, 2005.
引用
收藏
页码:549 / 565
页数:17
相关论文
共 146 条
[1]  
Abergel Chantal, 2003, Journal of Structural and Functional Genomics, V4, P141, DOI 10.1023/A:1026177202925
[2]   Mass spectrometry-based proteomics [J].
Aebersold, R ;
Mann, M .
NATURE, 2003, 422 (6928) :198-207
[3]   CAULOBACTER-CRESCENTUS CELL-ENVELOPE - EFFECT OF GROWTH-CONDITIONS ON MUREIN AND OUTER MEMBRANE-PROTEIN COMPOSITION [J].
AGABIAN, N ;
UNGER, B .
JOURNAL OF BACTERIOLOGY, 1978, 133 (02) :987-994
[4]   Virulence as a target for antimicrobial chemotherapy [J].
Alksne, LE .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2002, 11 (08) :1149-1159
[5]   New antibiotic discovery, novel screens, novel targets and impact of microbial genomics [J].
Allsop, AE .
CURRENT OPINION IN MICROBIOLOGY, 1998, 1 (05) :530-534
[6]  
[Anonymous], 2002, MMWR MORB MORTAL WKL, V51, P565
[7]   Peptide deformylase as an antibacterial drug target:: Target validation and resistance development [J].
Apfel, CM ;
Locher, H ;
Evers, S ;
Takács, B ;
Hubschwerlen, C ;
Pirson, W ;
Page, MGP ;
Keck, W .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (04) :1058-1064
[8]   Resistance among Streptococcus pneumoniae:: Implications for drug selection [J].
Appelbaum, PC .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (12) :1613-1620
[9]   Thinking and decision making, bacterial style: Bacterial Neural Networks, Obernai, France, 7th-12th June 2002 [J].
Armitage, JR ;
Dorman, CJ ;
Hellingwerf, K ;
Schmitt, R ;
Summers, D ;
Holland, B .
MOLECULAR MICROBIOLOGY, 2003, 47 (02) :583-593
[10]   Trends in infectious disease mortality in the United States during the 20th century [J].
Armstrong, GL ;
Conn, LA ;
Pinner, RW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (01) :61-66